You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab

Article info

Article menu

Download PDFPDF

XML
Case Report
Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab

Authors

  • Luciana Molinero Oncology Biomarker Development, PDCO-ImmunolotherapyGenentech, Incorporated 1 DNA Way MS: 245c 94080 South San Francisco CA USA PubMed articlesGoogle scholar articles
  • Yijin Li Oncology Biomarker Development, PDCO-ImmunolotherapyGenentech, Incorporated 1 DNA Way MS: 245c 94080 South San Francisco CA USA PubMed articlesGoogle scholar articles
  • Ching-Wei Chang Oncology Biomarker Development, PDCO-ImmunolotherapyGenentech, Incorporated 1 DNA Way MS: 245c 94080 South San Francisco CA USA PubMed articlesGoogle scholar articles
  • Sophia Maund Oncology Biomarker Development, PDCO-ImmunolotherapyGenentech, Incorporated 1 DNA Way MS: 245c 94080 South San Francisco CA USA PubMed articlesGoogle scholar articles
  • Maureen Berg School of Medicine, Oncology/ImmunologyJohns Hopkins University The Skip Viragh Outpatient Cancer Building, Floor 8, Viragh 8200-30, Box 11, 201 N Broadway 21287 Baltimore MD USA PubMed articlesGoogle scholar articles
  • Jeanne Harrison School of Medicine, Oncology/ImmunologyJohns Hopkins University The Skip Viragh Outpatient Cancer Building, Floor 8, Viragh 8200-30, Box 11, 201 N Broadway 21287 Baltimore MD USA PubMed articlesGoogle scholar articles
  • Marcella Fassò Oncology Biomarker Development, PDCO-ImmunolotherapyGenentech, Incorporated 1 DNA Way MS: 245c 94080 South San Francisco CA USA PubMed articlesGoogle scholar articles
  • Carol O’Hear Oncology Biomarker Development, PDCO-ImmunolotherapyGenentech, Incorporated 1 DNA Way MS: 245c 94080 South San Francisco CA USA PubMed articlesGoogle scholar articles
  • Priti Hegde Oncology Biomarker Development, PDCO-ImmunolotherapyGenentech, Incorporated 1 DNA Way MS: 245c 94080 South San Francisco CA USA PubMed articlesGoogle scholar articles
  • Leisha A. Emens School of Medicine, Oncology/ImmunologyJohns Hopkins University The Skip Viragh Outpatient Cancer Building, Floor 8, Viragh 8200-30, Box 11, 201 N Broadway 21287 Baltimore MD USA Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins Baltimore USA University of Pittsburgh Medical Center, Hillman Cancer Center 5117 Centre Avenue, Room 1.46e 15213 Pittsburgh PA USA PubMed articlesGoogle scholar articles

Citation

Molinero L, Li Y, Chang C, et al
Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab
Journal for ImmunoTherapy of Cancer 2019;7:274. doi: 10.1186/s40425-019-0740-8
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.